Cargando…

Use of consumer wearables to monitor and predict pain in patients with sickle cell disease

BACKGROUND: In sickle cell disease (SCD), unpredictable episodes of acute severe pain, known as vaso-occlusive crises (VOC), disrupt school, work activities and family life and ultimately lead to multiple hospitalizations. The ability to predict VOCs would allow a timely and adequate intervention. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuong, Caroline, Utkarsh, Kumar, Stojancic, Rebecca, Subramaniam, Arvind, Fernandez, Olivia, Banerjee, Tanvi, Abrams, Daniel M., Fijnvandraat, Karin, Shah, Nirmish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634543/
https://www.ncbi.nlm.nih.gov/pubmed/37954032
http://dx.doi.org/10.3389/fdgth.2023.1285207
_version_ 1785132852677967872
author Vuong, Caroline
Utkarsh, Kumar
Stojancic, Rebecca
Subramaniam, Arvind
Fernandez, Olivia
Banerjee, Tanvi
Abrams, Daniel M.
Fijnvandraat, Karin
Shah, Nirmish
author_facet Vuong, Caroline
Utkarsh, Kumar
Stojancic, Rebecca
Subramaniam, Arvind
Fernandez, Olivia
Banerjee, Tanvi
Abrams, Daniel M.
Fijnvandraat, Karin
Shah, Nirmish
author_sort Vuong, Caroline
collection PubMed
description BACKGROUND: In sickle cell disease (SCD), unpredictable episodes of acute severe pain, known as vaso-occlusive crises (VOC), disrupt school, work activities and family life and ultimately lead to multiple hospitalizations. The ability to predict VOCs would allow a timely and adequate intervention. The first step towards this ultimate goal is to use patient-friendly and accessible technology to collect relevant data that helps infer a patient's pain experience during VOC. This study aims to: (1) determine the feasibility of remotely monitoring with a consumer wearable during hospitalization for VOC and up to 30 days after discharge, and (2) evaluate the accuracy of pain prediction using machine learning models based on physiological parameters measured by a consumer wearable. METHODS: Patients with SCD (≥18 years) who were admitted for a vaso-occlusive crisis were enrolled at a single academic center. Participants were instructed to report daily pain scores (0–10) in a mobile app (Nanbar) and to continuously wear an Apple Watch up to 30 days after discharge. Data included heart rate (in rest, average and variability) and step count. Demographics, SCD genotype, and details of hospitalization including pain scores reported to nurses, were extracted from electronic medical records. Physiological data from the wearable were associated with pain scores to fit 3 different machine learning classification models. The performance of the machine learning models was evaluated using: accuracy, F1, root-mean-square error and area under the receiver-operating curve. RESULTS: Between April and June 2022, 19 patients (74% HbSS genotype) were included in this study and followed for a median time of 28 days [IQR 22–34], yielding a dataset of 2,395 pain data points. Ten participants were enrolled while hospitalized for VOC. The metrics of the best performing model, the random forest model, were micro-averaged accuracy of 92%, micro-averaged F1-score of 0.63, root-mean-square error of 1.1, and area under the receiving operating characteristic curve of 0.9. CONCLUSION: Our random forest model accurately predicts high pain scores during admission for VOC and after discharge. The Apple Watch was a feasible method to collect physiologic data and provided accuracy in prediction of pain scores.
format Online
Article
Text
id pubmed-10634543
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106345432023-11-10 Use of consumer wearables to monitor and predict pain in patients with sickle cell disease Vuong, Caroline Utkarsh, Kumar Stojancic, Rebecca Subramaniam, Arvind Fernandez, Olivia Banerjee, Tanvi Abrams, Daniel M. Fijnvandraat, Karin Shah, Nirmish Front Digit Health Digital Health BACKGROUND: In sickle cell disease (SCD), unpredictable episodes of acute severe pain, known as vaso-occlusive crises (VOC), disrupt school, work activities and family life and ultimately lead to multiple hospitalizations. The ability to predict VOCs would allow a timely and adequate intervention. The first step towards this ultimate goal is to use patient-friendly and accessible technology to collect relevant data that helps infer a patient's pain experience during VOC. This study aims to: (1) determine the feasibility of remotely monitoring with a consumer wearable during hospitalization for VOC and up to 30 days after discharge, and (2) evaluate the accuracy of pain prediction using machine learning models based on physiological parameters measured by a consumer wearable. METHODS: Patients with SCD (≥18 years) who were admitted for a vaso-occlusive crisis were enrolled at a single academic center. Participants were instructed to report daily pain scores (0–10) in a mobile app (Nanbar) and to continuously wear an Apple Watch up to 30 days after discharge. Data included heart rate (in rest, average and variability) and step count. Demographics, SCD genotype, and details of hospitalization including pain scores reported to nurses, were extracted from electronic medical records. Physiological data from the wearable were associated with pain scores to fit 3 different machine learning classification models. The performance of the machine learning models was evaluated using: accuracy, F1, root-mean-square error and area under the receiver-operating curve. RESULTS: Between April and June 2022, 19 patients (74% HbSS genotype) were included in this study and followed for a median time of 28 days [IQR 22–34], yielding a dataset of 2,395 pain data points. Ten participants were enrolled while hospitalized for VOC. The metrics of the best performing model, the random forest model, were micro-averaged accuracy of 92%, micro-averaged F1-score of 0.63, root-mean-square error of 1.1, and area under the receiving operating characteristic curve of 0.9. CONCLUSION: Our random forest model accurately predicts high pain scores during admission for VOC and after discharge. The Apple Watch was a feasible method to collect physiologic data and provided accuracy in prediction of pain scores. Frontiers Media S.A. 2023-10-25 /pmc/articles/PMC10634543/ /pubmed/37954032 http://dx.doi.org/10.3389/fdgth.2023.1285207 Text en © 2023 Vuong, Utkarsh, Stojancic, Subramaniam, Fernandez, Banerjee, Abrams, Fijnvandraat and Shah. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Digital Health
Vuong, Caroline
Utkarsh, Kumar
Stojancic, Rebecca
Subramaniam, Arvind
Fernandez, Olivia
Banerjee, Tanvi
Abrams, Daniel M.
Fijnvandraat, Karin
Shah, Nirmish
Use of consumer wearables to monitor and predict pain in patients with sickle cell disease
title Use of consumer wearables to monitor and predict pain in patients with sickle cell disease
title_full Use of consumer wearables to monitor and predict pain in patients with sickle cell disease
title_fullStr Use of consumer wearables to monitor and predict pain in patients with sickle cell disease
title_full_unstemmed Use of consumer wearables to monitor and predict pain in patients with sickle cell disease
title_short Use of consumer wearables to monitor and predict pain in patients with sickle cell disease
title_sort use of consumer wearables to monitor and predict pain in patients with sickle cell disease
topic Digital Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634543/
https://www.ncbi.nlm.nih.gov/pubmed/37954032
http://dx.doi.org/10.3389/fdgth.2023.1285207
work_keys_str_mv AT vuongcaroline useofconsumerwearablestomonitorandpredictpaininpatientswithsicklecelldisease
AT utkarshkumar useofconsumerwearablestomonitorandpredictpaininpatientswithsicklecelldisease
AT stojancicrebecca useofconsumerwearablestomonitorandpredictpaininpatientswithsicklecelldisease
AT subramaniamarvind useofconsumerwearablestomonitorandpredictpaininpatientswithsicklecelldisease
AT fernandezolivia useofconsumerwearablestomonitorandpredictpaininpatientswithsicklecelldisease
AT banerjeetanvi useofconsumerwearablestomonitorandpredictpaininpatientswithsicklecelldisease
AT abramsdanielm useofconsumerwearablestomonitorandpredictpaininpatientswithsicklecelldisease
AT fijnvandraatkarin useofconsumerwearablestomonitorandpredictpaininpatientswithsicklecelldisease
AT shahnirmish useofconsumerwearablestomonitorandpredictpaininpatientswithsicklecelldisease